おすすめの製品
無菌性
sterile
品質水準
形状
powder
シェルフライフ
limited shelf life, expiry date on the label
アプリケーション
clinical testing
environmental
food and beverages
microbiology
保管温度
2-8°C
適合性
Staphylococcus spp.
SMILES記法
COc1cccc(OC)c1C(=O)N[C@H]2C3SC(C)(C)[C@@H](N3C2=O)C(O)=O
InChI
1S/C17H20N2O6S/c1-17(2)12(16(22)23)19-14(21)11(15(19)26-17)18-13(20)10-8(24-3)6-5-7-9(10)25-4/h5-7,11-12,15H,1-4H3,(H,18,20)(H,22,23)/t11-,12+,15-/m1/s1
InChI Key
RJQXTJLFIWVMTO-TYNCELHUSA-N
類似した製品をお探しですか? 訪問 製品比較ガイド
詳細
MRSA Selective Supplement is an antimicrobial supplement recommended for the selective isolation of Methicillin Resistant Staphylococcus aureus (MRSA) from clinical specimens.
アプリケーション
MRSA Selective Supplement has been used for the culturing of methicillin-resistant Staphylococcus aureus (MRSA).
構成
(バイアル単位。1バイアルは500 mLの培地の調製に十分な量です)
メチシリン 2 mg
メチシリン 2 mg
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Jan Code
51387-5VL:
51387-BULK:
51387-1VL:
51387-1VL-BULK:
51387-5VL-BULK:
Antibiotics (Basel, Switzerland), 9(10) (2020-10-04)
The overall aim of the current study was to test the hypotheses that (i) antibiotic resistance in bacteria were more frequent in clinically health pigs in intensified company owned, medium-scale farms (MSFs) (100-500 sows) than in pigs in family-owned, small-scale
Antibiotics (Basel, Switzerland), 9(8) (2020-07-30)
Methicillin-resistant Staphylococcus aureus (MRSA) is a prevalent nosocomial pathogen, causing a wide range of diseases. The increased frequency of MRSA isolates in hospitals and the emergence of vancomycin resistance have sparked the search for new control strategies. This study aimed
JCI insight, 5(15) (2020-07-08)
Critical illness is accompanied by the release of large amounts of the anaphylotoxin, C5a. C5a suppresses antimicrobial functions of neutrophils which is associated with adverse outcomes. The signaling pathways that mediate C5a-induced neutrophil dysfunction are incompletely understood. Healthy donor neutrophils
Frontiers in bioengineering and biotechnology, 8, 634-634 (2020-07-18)
The one-stage treatment of chronic osteomyelitis with S53P4 bioactive glass (BAG) granules has shown excellent results. However, these granules possess suboptimal handling properties. Therefore, new injectable S53P4 putty materials have been developed by the incorporation of a synthetic binder to
Materials (Basel, Switzerland), 12(10) (2019-05-17)
Biomaterials that have been newly implanted inside the body are the substratum targets for a "race for the surface", in which bacterial cells compete against eukaryotic cells for the opportunity to colonize the surface. A victory by the former often
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら(テクニカルサービス)